These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 19470063

  • 1. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients.
    Adişen E, Tekin O, Gülekon A, Gürer MA.
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):814-9. PubMed ID: 19470063
    [Abstract] [Full Text] [Related]

  • 2. [Management of severe psoriasis: about 50 cases].
    Daoud L, Dhaoui MR, Youssef S, Jaber K, Doss N.
    Tunis Med; 2007 Oct; 85(10):849-56. PubMed ID: 18236807
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S, Sharma VK.
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [Abstract] [Full Text] [Related]

  • 4. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
    Caca-Biljanovska NG, V'lckova-Laskoska MT.
    Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E, Erbil AH, Kurumlu Z, Taştan HB, Etikan I.
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [Abstract] [Full Text] [Related]

  • 6. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light.
    Abel EA, Goldberg LH, Farber EM.
    Arch Dermatol; 1980 Nov; 116(11):1257-61. PubMed ID: 7436431
    [Abstract] [Full Text] [Related]

  • 7. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR, Evans C, Russell MW.
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [Abstract] [Full Text] [Related]

  • 8. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.
    Christophers E, Griffiths CE, Gaitanis G, van de Kerkhof P.
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):921-5. PubMed ID: 16922938
    [Abstract] [Full Text] [Related]

  • 9. Treatments for chronic palmoplantar pustular psoriasis.
    Marsland AM, Griffiths CE.
    Skin Therapy Lett; 2001 Nov; 6(12):3-5. PubMed ID: 11753536
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V, Guareschi E.
    Dermatol Online J; 2010 Jul 15; 16(7):8. PubMed ID: 20673536
    [Abstract] [Full Text] [Related]

  • 11. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
    Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS.
    J Am Acad Dermatol; 2005 Mar 15; 52(3 Pt 1):434-44. PubMed ID: 15761421
    [Abstract] [Full Text] [Related]

  • 12. [Psoriasis. Therapeutic strategy].
    Dubertret L.
    Rev Prat; 1991 Oct 15; 41(22):2188-91. PubMed ID: 1784923
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F, Canturk T, Senturk N, Turanli AY.
    Clin Exp Dermatol; 2006 Jul 15; 31(4):520-4. PubMed ID: 16716153
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
    Flytström I, Stenberg B, Svensson A, Bergbrant IM.
    Br J Dermatol; 2008 Jan 15; 158(1):116-21. PubMed ID: 17986302
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study.
    Reitamo S, Erkko P, Remitz A, Lauerma AI, Montonen O, Harjula K.
    Arch Dermatol; 1993 Oct 15; 129(10):1273-9. PubMed ID: 8215491
    [Abstract] [Full Text] [Related]

  • 16. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P, Stevenson O, Berth-Jones J.
    Br J Dermatol; 2004 Apr 15; 150(4):741-6. PubMed ID: 15099371
    [Abstract] [Full Text] [Related]

  • 17. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis.
    Kim JY, Kang HY, Lee ES, Kim YC.
    J Dermatol; 2007 Jan 15; 34(1):37-40. PubMed ID: 17204099
    [Abstract] [Full Text] [Related]

  • 18. Adverse events from systemic therapies for psoriasis are common in clinical practice.
    Pearce DJ, Higgins KB, Stealey KH, Balkrishnan R, Crane MM, Camacho F, Fleischer AB, Feldman SR.
    J Dermatolog Treat; 2006 Jan 15; 17(5):288-93. PubMed ID: 17092859
    [Abstract] [Full Text] [Related]

  • 19. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
    Spuls PI, Tuut MK, van Everdingen JJ, de Rie MA, Werkgroep Psoriasis van de Nederlandse Vereniging voor Dermatologie en Venereologie.
    Ned Tijdschr Geneeskd; 2004 Oct 23; 148(43):2121-5. PubMed ID: 15553355
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
    Engin B, Oguz O.
    Int J Dermatol; 2005 Apr 23; 44(4):337-9. PubMed ID: 15811091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.